Publication date: Dec 03, 2024
Bariatric/metabolic surgery has been reported to reduce the incidence of severe coronavirus disease 2019 (COVID-19); however, its ability to reduce risk is controversial. Therefore, this study aimed to elucidate the incidence and severity of COVID-19 in bariatric patients in Japan. The first survey of patients infected with COVID-19 after bariatric/metabolic surgery until June 30, 2022, was sent to 83 Japanese institutions. A second survey was conducted in institutions that reported on COVID-19 patients. The severity of COVID-19 was compared between the general population and bariatric patients, and risk factors correlated with severity were also evaluated. Twenty-six institutions (31. 3%) reported 119 patients with COVID-19 after laparoscopic bariatric/metabolic surgery. There were no severe cases or deaths; however, moderate COVID-19 (pneumonia) was significantly more common in bariatric patients than in the general population (11. 4% vs. 1. 3%). The risk factors for moderate COVID-19 in bariatric patients included incurable dyslipidemia and infection before the 6th wave of the pandemic. In Japan, the number of moderate COVID-19 cases may be higher in bariatric patients than in the general population. This study did not show that bariatric/metabolic surgery reduces the risk of COVID-19 complications.
Concepts | Keywords |
---|---|
Coronavirus | Bariatric/metabolic surgery |
Dyslipidemia | COVID-19 |
Japanese | Japan |
Laparoscopic | Severity |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | coronavirus disease 2019 |
disease | MESH | pneumonia |
disease | MESH | dyslipidemia |
disease | MESH | infection |
disease | MESH | complications |
disease | MESH | Long Covid |